Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
Results for
"[search-keyword]"
Sponsor content
28 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Oxonal 10/5 oxycodone hydrochloride/naloxone hydrochloride 10 mg/5 mg modified release tablet blister.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Oxonal 40/20 oxycodone hydrochloride/naloxone hydrochloride 40 mg/20 mg modified release tablet blister.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Oxonal 20/10 oxycodone hydrochloride/naloxone hydrochloride 20 mg/10 mg modified release tablet blister.
-
Prescription medicine registrationActive ingredients: naloxone hydrochloride dihydrate, oxycodone hydrochloride.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BUPRENORPHINE AUP buprenorphine 25 microgram/hour transdermal drug delivery system sachet.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for B-PATCH buprenorphine 30 microgram/hour transdermal drug delivery system sachet.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for B-PATCH buprenorphine 25 microgram/hour transdermal drug delivery system sachet.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for B-PATCH buprenorphine 40 microgram/hour transdermal drug delivery system sachet.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BUPRENORPHINE AUP buprenorphine 30 microgram/hour transdermal drug delivery system sachet.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BUPRENORPHINE AUP buprenorphine 40 microgram/hour transdermal drug delivery system sachet.